(Q40412943)

English

Safety and immunogenicity of a DTaP-IPV(Vero) (serum-free) combination vaccine in comparison to DTaP-IPV(Mkc) when administered simultaneously with Haemophilus influenzae type B conjugate vaccine (PRP-T) in children at 2, 3.5, 5 and 16 months of age

scientific article published on 27 August 2008

In more languages

default for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

20 September 2017

Safety and immunogenicity of a DTaP-IPV(Vero) (serum-free) combination vaccine in comparison to DTaP-IPV(Mkc) when administered simultaneously with Haemophilus influenzae type B conjugate vaccine (PRP-T) in children at 2, 3.5, 5 and 16 months of age (English)

1 reference

Europe PubMed Central

PubMed publication ID

20 September 2017

Haemophilus influenzae

object named as

Haemophilus influenzae

1 reference

based on heuristic

inferred from title

6

object named as

Helena Käyhty

1 reference

Europe PubMed Central

PubMed publication ID

20 September 2017

1

object named as

Jacek J Pietrzyk

1 reference

Europe PubMed Central

PubMed publication ID

20 September 2017

2

object named as

Jacek Wysocki

1 reference

Europe PubMed Central

PubMed publication ID

20 September 2017

author name string

Jerzy Pejcz

3

1 reference

Europe PubMed Central

PubMed publication ID

20 September 2017

Andrzej Galaj

4

1 reference

Europe PubMed Central

PubMed publication ID

20 September 2017

Ewa Majda-Stanislawska

5

1 reference

Europe PubMed Central

PubMed publication ID

20 September 2017

Birgit Thierry-Carstensen

7

1 reference

Europe PubMed Central

PubMed publication ID

20 September 2017

Anders Mørup Jensen

8

1 reference

Europe PubMed Central

PubMed publication ID

20 September 2017

language of work or name

0 references

publication date

27 August 2008

1 reference

Europe PubMed Central

PubMed publication ID

20 September 2017

1 reference

Europe PubMed Central

PubMed publication ID

20 September 2017

26

1 reference

Europe PubMed Central

PubMed publication ID

20 September 2017

41

1 reference

Europe PubMed Central

PubMed publication ID

20 September 2017

5296-5303

1 reference

Europe PubMed Central

PubMed publication ID

20 September 2017

Use of combination vaccines is associated with improved coverage rates

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.07.033

7 January 2021

Development and clinical testing of multivalent vaccines based on a diphtheria–tetanus–acellular pertussis vaccine: difficulties encountered and lessons learned

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.07.033

7 January 2021

A liquid hexavalent combined vaccine against diphtheria, tetanus, pertussis, poliomyelitis, Haemophilus influenzae type B and hepatitis B: review of immunogenicity and safety

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.07.033

7 January 2021

A fully liquid diphtheria-tetanus-five component acellular pertussis-inactivated poliomyelitis--Haemophilus influenzae type b conjugate vaccine: immunogenicity and safety of primary vaccination in Taiwanese infants

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.07.033

7 January 2021

Micro cell culture method for determination of diphtheria toxin and antitoxin titres using VERO cells. I. Studies on factors affecting the toxin and antitoxin titration

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.07.033

7 January 2021

The toxin binding inhibition test as a reliable in vitro alternative to the toxin neutralization test in mice for the estimation of tetanus antitoxin in human sera

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.07.033

7 January 2021

Serological correlates in whooping cough

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.07.033

7 January 2021

Interval estimation for the difference between independent proportions: comparison of eleven methods

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.07.033

7 January 2021

Immunogenicity and safety of a tetravalent diphtheria-tetanus-acellular pertussis-inactivated poliovirus vaccine

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.07.033

7 January 2021

Immunogenicity and reactogenicity of diphtheria, tetanus and pertussis toxoids combined with inactivated polio vaccine, when administered concomitantly with or as a diluent for a Hib conjugate vaccine.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.07.033

7 January 2021

Comparison of the immunogenicity and reactogenicity of two commercially available hexavalent vaccines administered as a primary vaccination course at 2, 4 and 6 months of age

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.07.033

7 January 2021

Safety, reactogenicity and immunogenicity of a combined hexavalent tetanus, diphtheria, acellular pertussis, hepatitis B, inactivated poliovirus vaccine and Haemophilus influenzae type b conjugate vaccine, for primary immunization of infants

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.07.033

7 January 2021

Evaluation of the immunogenicity and reactogenicity of a DTPa-HBV-IPV combination vaccine Co-administered with a hib conjugate vaccine either as a single injection of a hexavalent combination or as two separate injections at 3, 5 and 11 months of age

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.07.033

7 January 2021

A Placebo-Controlled Trial of a Pertussis-Toxoid Vaccine

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.07.033

7 January 2021

Large scale safety study of a liquid hexavalent vaccine (D-T-acP-IPV-PRP--T-HBs) administered at 2, 4, 6 and 12-14 months of age.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.07.033

7 January 2021

A combined diphtheria, tetanus, five-component acellular pertussis, poliovirus and Haemophilus influenzae type b vaccine

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.07.033

7 January 2021

Clinical experience of a tricomponent acellular pertussis vaccine combined with diphtheria and tetanus toxoids for primary vaccination in 22,505 infants

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.07.033

7 January 2021

Reactogenicity and immunogenicity of a booster dose of a combined diphtheria, tetanus, and tricomponent acellular pertussis vaccine at fourteen to twenty-eight months of age

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.07.033

7 January 2021

Assessment of nine candidate DTP-vaccines with reduced amount of antigen and/or without adjuvant as a fourth (booster-) dose in the second year of life.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.07.033

7 January 2021

Immunogenicity in infants of a vaccine composed of Haemophilus influenzae type b capsular polysaccharide mixed with DPT or conjugated to diphtheria toxoid

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.07.033

7 January 2021

An ELISA employing a Haemophilus influenzae type b oligosaccharide-human serum albumin conjugate correlates with the radioantigen binding assay

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.07.033

7 January 2021

Persistent itching nodules after the fourth dose of diphtheria-tetanus toxoid vaccines without evidence of delayed hypersensitivity to aluminium

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.07.033

7 January 2021

Extensive swelling after booster doses of acellular pertussis-tetanus-diphtheria vaccines

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.07.033

7 January 2021

Extensive swelling reactions occurring after booster doses of diphtheria-tetanus-acellular pertussis vaccines

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.07.033

7 January 2021

Ultrasound examination of extensive limb swelling reactions after diphtheria-tetanus-acellular pertussis or reduced-antigen content diphtheria-tetanus-acellular pertussis immunization in preschool-aged children

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.07.033

7 January 2021

Elimination of interfering activity in serum samples in the Chinese hamster ovary pertussis serology assay

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.07.033

7 January 2021

The protective level of serum antibodies to the capsular polysaccharide of Haemophilus influenzae type b

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.07.033

7 January 2021

The protective level of serum antibodies to the capsular polysaccharide of Haemophilus influenzae type b

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.07.033

7 January 2021

Identifiers

10.1016/J.VACCINE.2008.07.033

1 reference

Europe PubMed Central

PubMed publication ID

20 September 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

20 September 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q40412943&oldid=2149745046"